Investigation launched into HCA Healthcare over profit guidance cut and stock drop
Pomerantz LLP is investigating HCA Healthcare and some of its executives for possible securities fraud after the company sharply lowered its 2026 profit guidance due to an unfavorable payer mix, which reduced revenue by about $400 million in Q2. Foll...
